<DOC>
	<DOCNO>NCT00242736</DOCNO>
	<brief_summary>The purpose study evaluate whether difference proportion patient resolution heartburn symptom related gastroesophageal reflux disease ( GERD ) four week treatment esomeprazole ( NEXIUM® ) subject Erosive Esophagitis ( EE ) without EE .</brief_summary>
	<brief_title>An Open-Label Study Once-Daily Oral Administration Esomeprazole 40 mg Patients With Symptoms Gastroesophageal Reflux Disease ( GERD )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Symptoms GERD define protocol : Heartburn ( severity mild , moderate severe ) 2 time 7 day prior Screening visit ( Visit 1 ) , average , least 2 time per week past 3 month . Male female , 18 70 year old , inclusive . Nonpregnant , nonlactating female patient . Female patient must postmenopausal , surgically sterile , use medically acceptable form birth control , determine investigator . Females childbearing potential must agree continue use acceptable form birth control throughout conduct study . Negative urine pregnancy test female childbearing potential . Willingness adhere protocol requirement . Previous enrollment present study . Significant clinical illness within 2 week prior first dose study medication significant illness study . Use PPI , include PRILOSEC OTC® , within 21 day Screening ( Visit 1 ) anytime study ( Visit 1 Visit 4 ) . Daily therapy H2 RA within 14 day Screening ( Visit 1 ) : eg , ranitidine ( ZANTAC® ) , cimetidine ( TAGAMET® ) , nizatidine ( AXID® ) , famotidine ( PEPCID® ) ( occasional use ; ie , less daily , permit ) . Use H2 RAs frequency prohibit throughout entire study ( Visit 1 Visit 4 ) . A history gastric esophageal surgery ( include , limited , Nissen fundoplication bariatric surgery ) , except simple closure perforate ulcer procedure would affect study determine Clinical Study Team physician AstraZeneca . Clinically significant gastrointestinal ( GI ) bleeding ( eg , melena , frank hematochezia ) within 3 day Screening ( Visit 1 ) note time baseline EGD . Nonacid related etiology esophagitis ( eg , pillinduced , caustic ingestion eosinophilic esophagitis ) . Generalized bleed disorder result hemorrhagic diathesis ( abnormality clot factor platelet ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>